Host: |
HEK293 cells |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Formulation: |
Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Determination Method: |
< 0.1 EU/Mu g |
Immunoreactivity: |
Measured by its ability to mediate Balb/3T3 mouse embryonic fibroblast cell adhesion. Recombinant Human Cyr61/CCN1 Fc Chimera immobilized at 1.5 Mu g/mL (100 Mu L/well) , will mediate >25% BALB/3T3 cell adhesion (3 x 104 cell/well added). |
Gene Symbol: |
CCN1 |
Gene ID: |
3491 |
Uniprot ID: |
CCN1_HUMAN |
Immunogen Region: |
Thr25-Asp381 |
Immunogen: |
Recombinant Human Cyr61/CCN1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Thr25-Asp381) of human Cyr61/CCN1 (Accession #O00622) fused with a hFc tag at the C-terminus. |
Immunogen Sequence: |
TCPAACHCPLEAPKCAPGVG LVRDGCGCCKVCAKQLNEDC SKTQPCDHTKGLECNFGASS TALKGICRAQSEGRPCEYNS RIYQNGESFQPNCKHQCTCI DGAVGCIPLCPQELSLPNLG CPNPRLVKVTGQCCEEWVCD EDSIKDPMEDQDGLLGKELG FDASEVELTRNNELIAVGKG SSLKRLPVFGMEPRILYNPL QGQKCIVQTTSWSQCSKTCG TGISTRVTNDNPECRLVKE |
Protein Name | Ccn Family Member 1Cellular Communication Network Factor 1Cysteine-Rich Angiogenic Inducer 61Insulin-Like Growth Factor-Binding Protein 10Ibp-10Igf-Binding Protein 10Igfbp-10Protein Cyr61Protein Gig1 |
Database Links | Reactome: R-HSA-381426Reactome: R-HSA-8957275 |
Cellular Localisation | Secreted |
Alternative Protein Names | Ccn Family Member 1 proteinCellular Communication Network Factor 1 proteinCysteine-Rich Angiogenic Inducer 61 proteinInsulin-Like Growth Factor-Binding Protein 10 proteinIbp-10 proteinIgf-Binding Protein 10 proteinIgfbp-10 proteinProtein Cyr61 proteinProtein Gig1 proteinCCN1 proteinCYR61 proteinGIG1 proteinIGFBP10 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance